T cell receptor (TCR) engagement in apoptosis-defective, but interleukin 2 (IL-2)-producing, T cells results in impaired ZAP70/CD3-ζ association

被引:35
作者
Sahuquillo, AG
Roumier, A
Teixeiro, E
Bragado, R
Alarcón, B
机构
[1] Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain
[2] Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain
[3] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
关键词
D O I
10.1084/jem.187.8.1179
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously shown that a tyrosine to leucine replacement in the transmembrane region of T cell receptor (TCR)-beta results in a deficient induction of CD95-L aid apoptosis upon TCR triggering in a transfected T cell line. By contrast, interleukin (IL)-2 production and the expression of CD25 and CD69 were normally induced. Since the mutation in TCR-beta also resulted in impaired association of CD3-zeta, it was proposed that this chain is specifically required for die induction of apoptosis. We now show that the deficient induction of CD95-L and apoptosis does not derive from a general lower production of second messengers, since intracellular Ca2+ fluxes and tyrosine phosphorylation of total proteins were elicited at wild-type levels. Unlike in T cell crones stimulated with partial agonists, both p21 and p18 forms of tyrosine-phosphorylated CD3-zeta were detected, although the overall level of tyrosine-phosphorylated CD3-zeta was low. More strikingly, inducible association of ZAP70 to CD3-zeta was strongly inhibited, despite a normal induction of ZAP70 tyrosine phosphorylation. Finally, ZAP70 was not concentrated near the plasma membrane ill the apoptosis-deficient cells. These results suggest that CD3-zeta is necessary for engagement of a specific signaling pathway leading to CD95-L expression that also needs the recruitment of ZAP70.
引用
收藏
页码:1179 / 1192
页数:14
相关论文
共 60 条
[11]   P56(LCK) INTERACTS VIA ITS SRC HOMOLOGY-2 DOMAIN WITH THE ZAP-70 KINASE [J].
DUPLAY, P ;
THOME, M ;
HERVE, F ;
ACUTO, O .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1163-1172
[12]  
Eischen CM, 1997, J IMMUNOL, V159, P1135
[13]  
EXLEY M, 1994, J BIOL CHEM, V269, P15140
[14]  
GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104
[15]   Proximity and orientation underlie signaling by the non-receptor tyrosine kinase ZAP70 [J].
Graef, IA ;
Holsinger, LJ ;
Diver, S ;
Schreiber, SL ;
Crabtree, GR .
EMBO JOURNAL, 1997, 16 (18) :5618-5628
[16]  
GRANJA C, 1991, J BIOL CHEM, V266, P16277
[17]   Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice [J].
Hodge, MR ;
Ranger, AM ;
delaBrousse, FC ;
Hoey, T ;
Grusby, MJ ;
Glimcher, LH .
IMMUNITY, 1996, 4 (04) :397-405
[18]   ZAP-70 protein tyrosine kinase is constitutively targeted to the T cell cortex independently of its SH2 domains [J].
Huby, RDJ ;
Iwashima, M ;
Weiss, A ;
Ley, SC .
JOURNAL OF CELL BIOLOGY, 1997, 137 (07) :1639-1649
[19]   Interactions between the protein-tyrosine kinase ZAP-70, the proto-oncoprotein Vav, and tubulin in Jurkat T cells [J].
Huby, RDJ ;
Carlile, GW ;
Ley, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30241-30244
[20]   ZAP-70 BINDING-SPECIFICITY TO T-CELL RECEPTOR TYROSINE-BASED ACTIVATION MOTIFS - THE TANDEM SH2 DOMAINS OF ZAP-70 BIND DISTINCT TYROSINE-BASED ACTIVATION MOTIFS WITH VARYING AFFINITY [J].
ISAKOV, N ;
WANGE, RL ;
BURGESS, WH ;
WATTS, JD ;
AEBERSOLD, R ;
SAMELSON, LE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :375-380